Com2uS Unveils New Trailer for Mobile RPG Tougen Anki

Exciting news for fans of the supernatural action manga, Tougen Anki! Com2uS, the renowned developer behind the hit game Summoners War, is bringing this thrilling series to life in a new RPG for both mobile and PC. The game's announcement was made at Anime Japan 2025, held at Tokyo Big Sight, creating a buzz among attendees and fans alike.

Com2uS has released an enticing teaser that offers a sneak peek into the early visuals of Tougen Anki. The teaser showcases the game's commitment to staying true to the manga's distinctive art style, immersing players in its dark fantasy world through stunning 3D visuals. Check out the teaser below to get a glimpse of what's in store.

What Else Do We Know About Tougen Anki, Com2uS' Mobile RPG?

While Com2uS is keeping most details under wraps, the teaser reveals that the game will faithfully adapt the manga's art style. Collaborating with G-Holdings, Com2uS aims to deliver a multi-platform experience that resonates with fans. Although specifics about gameplay are yet to be disclosed, the developers have promised to maintain the source material's tone and narrative, while adding unique twists to enhance the gaming experience.

Read Tougen Anki?

For those unfamiliar with the source material, Tougen Anki is a supernatural action manga penned by Yura Urushibara, which debuted in June 2020 in Weekly Shōnen Champion. The series narrates the epic war between the descendants of Oni and Momotaro, packed with intense battles and deep family drama. With over three million copies sold, the manga has captured a wide audience. Yen Press began publishing the English version in September 2024, and it has also inspired stage play adaptations in Tokyo and Osaka. Fans can look forward to an anime TV series adaptation set to premiere in July 2025.

For more information about Tougen Anki, visit the official website. Before you go, don't miss our coverage on The Seven Deadly Sins: Idle Adventure's latest update featuring the Emperor of Light Escanor.